Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 235 (8%) | |
| Anticipated shortage: | 19 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2019-12-12 | 2020-01-07 | 101094 |
| APO-HYDRALAZINE | 50MG | TABLET | Resolved | 2020-01-29 | 2020-02-28 | 104694 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2020-04-22 | 2020-05-20 | 112738 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2021-05-25 | 2021-07-15 | 139842 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2021-06-18 | 2021-07-15 | 141238 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2022-10-28 | 2023-01-06 | 172882 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2022-11-11 | 2022-12-23 | 174332 |
| APO-HYDRALAZINE | 10MG | TABLET TABLET | Resolved | 2022-11-27 | 2022-12-23 | 175889 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2023-09-22 | 2023-11-06 | 204999 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-01-19 | 2024-04-05 | 216650 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2017-07-25 | 2017-09-15 | 16931 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2017-10-11 | 2018-03-06 | 25210 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2018-12-12 | 2019-01-17 | 69302 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2019-03-05 | 2019-03-29 | 77887 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2020-09-02 | 2020-09-09 | 123566 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2023-11-10 | 2023-11-17 | 209942 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223083 |
| APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2017-07-31 | 2017-09-06 | 17605 |
| APO-HYDROMORPHONE | 1MG | TABLET | Resolved | 2017-08-23 | 2017-09-01 | 20105 |
| APO-HYDROMORPHONE | 1MG | TABLET | Resolved | 2017-10-11 | 2018-01-22 | 25214 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
| APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |
| APO-TADALAFIL | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-02-13 | 61045 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-09-12 | 61050 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
| APO-TERAZOSIN | 5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4749 |
| APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 |